LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024
LeMaitre Vascular (Nasdaq:LMAT) has announced that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
Interested parties can access the live call by registering online, after which they will receive dial-in information and a PIN. An audio webcast will also be available live and for replay at www.lemaitre.com/investor.
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition affecting over 200 million people worldwide. The company focuses on developing, manufacturing, and marketing disposable and implantable vascular devices for vascular surgeons.
LeMaitre Vascular (Nasdaq:LMAT) ha annunciato che rilascerà i risultati finanziari del terzo trimestre 2024 il giovedì 31 ottobre 2024, dopo la chiusura del mercato. L'azienda ha programmato una conference call per le 17:00 ET lo stesso giorno per discutere i risultati, i punti salienti aziendali e le prospettive della società.
Le parti interessate possono accedere alla chiamata dal vivo registrandosi online, dopo di che riceveranno le informazioni per il collegamento e un PIN. Sarà anche disponibile una webcast audio in diretta e per la riproduzione su www.lemaitre.com/investor.
LeMaitre è un fornitore di dispositivi, impianti e servizi per il trattamento delle malattie vascolari periferiche, una condizione che colpisce oltre 200 milioni di persone nel mondo. L'azienda si concentra sullo sviluppo, la produzione e la commercializzazione di dispositivi vascolari monouso e impiantabili per i chirurghi vascolari.
LeMaitre Vascular (Nasdaq:LMAT) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el jueves 31 de octubre de 2024, después del cierre del mercado. La compañía ha programado una conferencia telefónica a las 5:00 PM ET el mismo día para discutir los resultados, los aspectos destacados del negocio y las perspectivas de la empresa.
Las partes interesadas pueden acceder a la llamada en vivo registrándose en línea, después de lo cual recibirán información para marcar y un PIN. También habrá una transmisión de audio disponible en vivo y para repetición en www.lemaitre.com/investor.
LeMaitre es un proveedor de dispositivos, implantes y servicios para el tratamiento de enfermedades vasculares periféricas, una afección que afecta a más de 200 millones de personas en todo el mundo. La empresa se centra en desarrollar, fabricar y comercializar dispositivos vasculares desechables e implantables para cirujanos vasculares.
LeMaitre Vascular (Nasdaq:LMAT)는 2024년 3분기 재무 결과를 2024년 10월 31일 목요일 시장 마감 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 5:00 ET에 결과, 비즈니스 하이라이트 및 회사 전망에 대해 논의하기 위한 컨퍼런스 콜을 예정하고 있습니다.
관심 있는 이들은 온라인 등록을 통해 실시간 통화에 접근할 수 있으며, 이후 다이얼인 정보와 PIN을 받게 됩니다. 또한 오디오 웹캐스트가 www.lemaitre.com/investor에서 실시간으로 제공되고 재생할 수 있습니다.
LeMaitre는 말초혈관 질환 치료를 위한 장치, 임플란트 및 서비스를 제공하는 회사로, 전 세계적으로 2억 명 이상의 사람들에게 영향을 미치는 질환입니다. 이 회사는 혈관외과 의사를 위한 일회용 및 이식 가능한 혈관 장치의 개발, 제조 및 마케팅에 중점을 두고 있습니다.
LeMaitre Vascular (Nasdaq:LMAT) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 le jeudi 31 octobre 2024, après la clôture du marché. L'entreprise a prévu une conférence téléphonique à 17h00 ET le même jour pour discuter des résultats, des points saillants de l'entreprise et des perspectives.
Les parties intéressées peuvent accéder à l'appel en direct en s'inscrivant en ligne, après quoi elles recevront des informations de connexion et un code PIN. Un webinaire audio sera également disponible en direct et en rediffusion sur www.lemaitre.com/investor.
LeMaitre est un fournisseur de dispositifs, d'implants et de services pour le traitement des maladies vasculaires périphériques, une affection qui touche plus de 200 millions de personnes dans le monde. L'entreprise se concentre sur le développement, la fabrication et la commercialisation de dispositifs vasculaires jetables et implantables pour les chirurgiens vasculaires.
LeMaitre Vascular (Nasdaq:LMAT) hat angekündigt, dass es am Donnerstag, den 31. Oktober 2024 nach Marktende seine Finanzergebnisse für das dritte Quartal 2024 veröffentlichen wird. Das Unternehmen hat für denselben Tag um 17:00 Uhr ET eine Telefonkonferenz angesetzt, um die Ergebnisse, geschäftliche Highlights und die Unternehmensprognose zu besprechen.
Interessierte Parteien können über Online-Registrierung auf den Live-Anruf zugreifen, nach dem sie Dial-in-Informationen und eine PIN erhalten. Auch eine Audio-Webcast wird live und zur Wiedergabe unter www.lemaitre.com/investor verfügbar sein.
LeMaitre ist ein Anbieter von Geräten, Implantaten und Dienstleistungen zur Behandlung von peripheren Gefäßerkrankungen, einer Erkrankung, die über 200 Millionen Menschen weltweit betrifft. Das Unternehmen konzentriert sich auf die Entwicklung, Herstellung und Vermarktung von Einweg- und implantierbaren Gefäßgeräten für Gefäßchirurgen.
- None.
- None.
BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
FAQ
When will LeMaitre Vascular (LMAT) release its Q3 2024 earnings?
What time is LeMaitre Vascular's (LMAT) Q3 2024 earnings call scheduled?
How can investors access LeMaitre Vascular's (LMAT) Q3 2024 earnings call?
What is LeMaitre Vascular's (LMAT) main business focus?
